SANOFI INDIA Financial Statement Analysis
|
||
|
The Revenues of SANOFI INDIA have decreased by -27.94% YoY .
The Earnings Per Share (EPS) of SANOFI INDIA has decreased by -13.96 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SANOFI INDIA Last 5 Annual Financial Results
[BOM: 500674|NSE : SANOFI]
| Standalone | Dec2024 | Dec2023 | Dec2022 | Dec2021 | Dec2020 |
|---|---|---|---|---|---|
| Revenues | ₹1,996 Cr | ₹2,770 Cr | ₹2,957 Cr | ₹2,902 Cr | ₹3,071 Cr |
| Expenses | ₹1,509 Cr | ₹2,067 Cr | ₹2,194 Cr | ₹2,189 Cr | ₹2,405 Cr |
| Operating Profit (Excl OI) | ₹487 Cr | ₹703 Cr | ₹762 Cr | ₹713 Cr | ₹665 Cr |
| Other Income | ₹62 Cr | ₹73 Cr | ₹75 Cr | ₹90 Cr | ₹94 Cr |
| Interest | ₹1.70 Cr | ₹1.70 Cr | ₹1.80 Cr | ₹1.80 Cr | ₹0.30 Cr |
| Depreciation | ₹37 Cr | ₹42 Cr | ₹67 Cr | ₹82 Cr | ₹100 Cr |
| Profit Before Tax | ₹529 Cr | ₹864 Cr | ₹1,258 Cr | ₹677 Cr | ₹600 Cr |
| Profit After Tax | ₹365 Cr | ₹621 Cr | ₹944 Cr | ₹478 Cr | ₹414 Cr |
| Earnings Per Share (Rs) | ₹136.39 | ₹158.52 | ₹269.83 | ₹410.61 | ₹207.65 |
| PAT Margin (%) | 15.20 | 17.59 | 21.27 | 31.94 | 16.46 |
| ROE(%) | 36.09 | 33.75 | 36.73 | 44.65 | 21.39 |
| ROCE(%) | 46.15 | 46.28 | 49.47 | 57.98 | 29.77 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 10,152.8 Cr |
| Revenue (TTM) | : | ₹ 1,932.5 Cr |
| Net Profit(TTM) | : | ₹ 356.3 Cr |
| EPS (TTM) | : | ₹ 154.9 |
| P/E (TTM) | : | 28.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SANOFI INDIA | -3.4% | -6.2% | -27.6% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.5% | 6.5% | -1.5% |
| DIVIS LABORATORIES | 0.8% | 0.3% | 6.9% |
| CIPLA | -0.4% | -3.8% | 1.4% |
| TORRENT PHARMACEUTICALS | 1% | 4.4% | 18.1% |
| DR REDDYS LABORATORIES | 0.1% | -2.8% | 1.8% |
| MANKIND PHARMA | 1% | -6.5% | -12.1% |
| ZYDUS LIFESCIENCES | 1.4% | -7.2% | -2.2% |
| LUPIN | 2% | 7.8% | -1.3% |
SANOFI INDIA Revenues
[BOM: 500674|NSE : SANOFI]
| Y-o-Y | -27.94 % |
| 5 Yr CAGR | -10.21 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Dec2024 | ₹1,996 Cr | -27.94 | |
| Dec2023 | ₹2,770 Cr | -6.31 | |
| Dec2022 | ₹2,957 Cr | 1.88 | |
| Dec2021 | ₹2,902 Cr | -5.49 | |
| Dec2020 | ₹3,071 Cr | - | |
SANOFI INDIA Operating Profit
[BOM: 500674|NSE : SANOFI]
| Y-o-Y | -30.70 % |
| 5 Yr CAGR | -7.50 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Dec2024 | ₹487 Cr | -30.70 | |
| Dec2023 | ₹703 Cr | -7.79 | |
| Dec2022 | ₹762 Cr | 6.90 | |
| Dec2021 | ₹713 Cr | 7.18 | |
| Dec2020 | ₹665 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -3.82 % |
| 5 Yr CAGR | 3.01 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2024 | 24.4% | -3.82 | |
| Dec2023 | 25.37% | -1.59 | |
| Dec2022 | 25.78% | 4.92 | |
| Dec2021 | 24.57% | 13.38 | |
| Dec2020 | 21.67% | - | |
SANOFI INDIA Profit After Tax
[BOM: 500674|NSE : SANOFI]
| Y-o-Y | -41.25 % |
| 5 Yr CAGR | -3.14 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2024 | ₹365 Cr | -41.25 | |
| Dec2023 | ₹621 Cr | -34.29 | |
| Dec2022 | ₹944 Cr | 97.74 | |
| Dec2021 | ₹478 Cr | 15.31 | |
| Dec2020 | ₹414 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -13.59 % |
| 5 Yr CAGR | -1.97 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2024 | 15.2 % | -13.59 | |
| Dec2023 | 17.59 % | -17.30 | |
| Dec2022 | 21.27 % | -33.41 | |
| Dec2021 | 31.94 % | 94.05 | |
| Dec2020 | 16.46 % | - | |
SANOFI INDIA Earnings Per Share (EPS)
[BOM: 500674|NSE : SANOFI]
| Y-o-Y | -13.96 % |
| 5 Yr CAGR | -9.98 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Dec2024 | ₹136 | -13.96 | |
| Dec2023 | ₹159 | -41.25 | |
| Dec2022 | ₹270 | -34.29 | |
| Dec2021 | ₹411 | 97.74 | |
| Dec2020 | ₹208 | - | |
SANOFI INDIA Return on Capital Employed (ROCE)
[BOM: 500674|NSE : SANOFI]
| Y-o-Y | -0.28 % |
| 5 Yr CAGR | 11.58 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Dec2024 | 46.15% | -0.28 | |
| Dec2023 | 46.28% | -6.45 | |
| Dec2022 | 49.47% | -14.68 | |
| Dec2021 | 57.98% | 94.76 | |
| Dec2020 | 29.77% | - | |
SANOFI INDIA Share Price vs Sensex
| Current Share Price | : | ₹4,414.3 |
| Current MarketCap | : | ₹ 10,152.8 Cr |
| Updated EOD on | : | Nov 26,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANOFI INDIA | -3.4% |
-6.2% |
-27.6% |
| SENSEX | 0.5% |
1.7% |
11% |
SANOFI INDIA related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE HEALTHCARE | 0.3% | -0.2% | 5.5% |
| BSE 500 | 0.2% | 1.1% | 9.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY TOTAL MARKET | 0.2% | 1% | 9.4% |
| NIFTY MICROCAP 250 | -1% | -1.8% | -1.2% |
You may also like the below Video Courses
FAQ about SANOFI INDIA Financials
How the annual revenues of SANOFI INDIA have changed ?
The Revenues of SANOFI INDIA have decreased by -27.94% YoY .
How the Earnings per Share (EPS) of SANOFI INDIA have changed?
The Earnings Per Share (EPS) of SANOFI INDIA has decreased by -13.96 % YoY .
Check out Intrinsic Value of Peers of SANOFI INDIA
Compare Stock Analytics of Peers of SANOFI INDIA
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
